| GTO ID |
GTD0327 |
| Accession |
E-MTAB-11315
|
| Gene therapy-related clinical trial |
GTC2404 |
| Altered gene |
S |
| Gene xrefs |
Gene ID:
1489668
|
| Treatment |
ARCT-021(ARCT COVID-19 vaccine) |
| Control |
Click to openARCT.101.1102.Day2_06;ARCT.101.1107.Day2_11;ARCT.101.2103.Day2_08;ARCT.101.2106.Day2_05;ARCT.101.2108.Day2_02;ARCT.101.2111.Day2_02;ARCT.101.3101.Day2_02;ARCT.101.3104.Day2_11;ARCT.101.4103.Day2_10;ARCT.101.4107.Day2_02;ARCT.101.4117.Day2_12;ARCT.101.4119.Day2_06;ARCT.101.5104.Day2_04;ARCT.101.5108.Day2_11;ARCT.101.5109.Day2_09;ARCT.101.5116.Day2_12;ARCT.101.6103.Day2_10;ARCT.101.6108.Day2_06;ARCT.101.6110.Day2_02;ARCT.101.6111.Day2_06;ARCT.101.7103.Day2_04;ARCT.101.7105.Day2_10;ARCT.101.7108.Day2_02;ARCT.101.7115.Day2_06;ARCT.101.8105.Day2_04;ARCT.101.8106.Day2_08;ARCT.101.8109.Day2_08;ARCT.101.8112.Day2_08 |
| Case |
Click to openARCT.101.2101.Day2_02;ARCT.101.2102.Day2_05;ARCT.101.2104.Day2_11;ARCT.101.2105.Day2_02;ARCT.101.2107.Day2_08;ARCT.101.2109.Day2_06;ARCT.101.2110.Day2_10;ARCT.101.2112.Day2_06;ARCT.101.2113.Day2_10;ARCT.101.2114.Day2_10;ARCT.101.5101.Day2_01;ARCT.101.5102.Day2_02;ARCT.101.5103.Day2_03;ARCT.101.5105.Day2_05;ARCT.101.5106.Day2_06;ARCT.101.5107.Day2_07;ARCT.101.5110.Day2_10;ARCT.101.5111.Day2_11;ARCT.101.5112.Day2_12;ARCT.101.5113.Day2_09;ARCT.101.5114.Day2_10;ARCT.101.5115.Day2_11;ARCT.101.7101.Day2_10;ARCT.101.7102.Day2_01;ARCT.101.7104.Day2_07;ARCT.101.7106.Day2_06;ARCT.101.7107.Day2_10;ARCT.101.7109.Day2_06;ARCT.101.7110.Day2_10;ARCT.101.7111.Day2_02;ARCT.101.7112.Day2_06;ARCT.101.7113.Day2_10;ARCT.101.7114.Day2_02;ARCT.101.7116.Day2_10 |
| Disease |
COVID-19 |
| Disease information |
Disease group: Infection
Definition: A Coronavirus infection that is characterized by fever, cough and shortness of breath and that has_material_basis_in SARS-CoV-2.
Xref:
DO:0080600
|
| Organism |
Homo sapiens |
| Tissue/Cell type |
blood |
| Characteristics |
Day2;5 microgram |
| Strategy |
Microarray |
| Platform |
A-MTAB-668 |